HIV moments and pre-exposure prophylaxis.
作者信息
Grant Robert M, Glidden David V
机构信息
Gladstone Institutes, San Francisco, CA, USA; University of California, San Francisco, CA, USA; San Francisco AIDS Foundation, San Francisco, CA, USA.
University of California, San Francisco, CA, USA.
出版信息
Lancet. 2016 Apr 9;387(10027):1507-1508. doi: 10.1016/S0140-6736(16)30125-8. Epub 2016 Apr 7.
Abstract
摘要
相似文献
1
HIV moments and pre-exposure prophylaxis.
Lancet. 2016 Apr 9;387(10027):1507-1508. doi: 10.1016/S0140-6736(16)30125-8. Epub 2016 Apr 7.
2
HIV moments and pre-exposure prophylaxis--Authors' reply.
Lancet. 2016 Apr 9;387(10027):1508. doi: 10.1016/S0140-6736(16)00695-4. Epub 2016 Apr 7.
3
[HIV pre-exposure prophylaxis does not increase the rate of STI].
Rev Med Suisse. 2016 Jan 27;12(503):236.
4
Infection: PrEParation to be PROUD of.
Nat Rev Urol. 2015 Nov;12(11):596. doi: 10.1038/nrurol.2015.225. Epub 2015 Oct 6.
5
ACP Journal Club. Preexposure tenofovir-emtricitabine reduced HIV infection in men who have unprotected anal sex with men.
Ann Intern Med. 2016 Jan 19;164(2):JC3. doi: 10.7326/ACPJC-2016-164-2-003.
6
Antiretroviral chemoprophylaxis: PROUD and pragmatism.
Lancet. 2016 Jan 2;387(10013):6-7. doi: 10.1016/S0140-6736(15)00153-1. Epub 2015 Sep 9.
7
[Progression of STI noted after initiation of EPESE for HIV].
Ann Dermatol Venereol. 2019 Oct;146(10):687-688. doi: 10.1016/j.annder.2019.05.006. Epub 2019 Jun 19.
8
Informal PrEP: an emerging need for nomenclature.
Lancet Public Health. 2019 Feb;4(2):e83. doi: 10.1016/S2468-2667(18)30254-8. Epub 2018 Dec 19.
9
HIV preexposure prophylaxis in Canadian primary care and community settings.
Can Fam Physician. 2019 Apr;65(4):271-272.
10
Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.
Expert Opin Drug Saf. 2016 Sep;15(9):1287-94. doi: 10.1080/14740338.2016.1211108. Epub 2016 Jul 25.
引用本文的文献
1
Factors Associated with Low/Moderate Perceived Risk for HIV Acquisition Among Gay, Bisexual, and Other Men Who Have Sex with Men Eligible to Use Pre-exposure Prophylaxis from Brazil, Mexico, and Peru.
Arch Sex Behav. 2025 Mar;54(3):1141-1152. doi: 10.1007/s10508-024-03078-y. Epub 2025 Jan 27.
2
Barriers and missed opportunities in PrEP uptake, use and care among men who have sex with men with recent HIV infection in the Netherlands.
PLoS One. 2025 Jan 6;20(1):e0310621. doi: 10.1371/journal.pone.0310621. eCollection 2025.
3
Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men.
AIDS Patient Care STDS. 2019 May;33(5):220-226. doi: 10.1089/apc.2018.0289.
4
Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda.
Clin Infect Dis. 2018 Nov 28;67(12):1853-1860. doi: 10.1093/cid/ciy390.
5
The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.
J Int AIDS Soc. 2018 Mar;21(3):e25096. doi: 10.1002/jia2.25096.
6
Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.
Clin Infect Dis. 2018 May 17;66(11):1712-1721. doi: 10.1093/cid/cix1086.
7
Family planning providers' role in offering PrEP to women.
Contraception. 2018 Jun;97(6):467-470. doi: 10.1016/j.contraception.2018.01.007. Epub 2018 Mar 9.
8
Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States.
AIDS Patient Care STDS. 2018 Jan;32(1):16-23. doi: 10.1089/apc.2017.0201.
本文引用的文献
1
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9.
2
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.
Lancet Infect Dis. 2014 Sep;14(9):820-9. doi: 10.1016/S1473-3099(14)70847-3. Epub 2014 Jul 22.
3
No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.
PLoS One. 2013 Dec 18;8(12):e81997. doi: 10.1371/journal.pone.0081997. eCollection 2013.
4
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.
Zotero 插件